HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans.

AbstractBACKGROUND:
Catecholamines govern stress blood pressure responses. Catecholaminergic responses may be partially genetic and contribute to the complex heritability of hypertension.
METHODS AND RESULTS:
To evaluate catecholaminergic responses without systemic counterregulation, we infused graded concentrations of tyramine, an indirect presynaptic norepinephrine releaser, into dorsal hand veins of 49 normotensive men and women of 5 ethnicities. Vascular responses were coupled to common (minor allele frequency >10%) single-nucleotide polymorphisms at adrenergic target loci within presynaptic pathways. Significance was set at P<0.003 after Bonferroni correction. Generalized analysis of molecular variance (GAMOVA) was performed to determine whether genetic admixture contributed to results. Venoconstriction progressed to 47% with increasing concentrations of tyramine (0.129 to 25.8 mmol/L; P<0.001). Family history of hypertension (P<0.001) and female sex (P=0.02) predicted blunted tyramine responses. Two genetic loci significantly predicted vascular response: chromogranin B, which encodes a protein that catalyzes catecholamine vesicle formation (CHGB, exon 4, Glu348Glu; P=0.002), and cytochrome b-561 (CYB561, intron 1, C719G; P<0.001), an electron shuttle for catecholamine synthesis. Stepwise regression suggested important effects for the CHGB locus, with polymorphisms for the vacuolar-ATPase beta-subunit (ATP6V1B1, exon 1, Ile30Thr) and flavin-containing monooxygenase-3 (FMO3, exon 3, Lys158Glu, P=0.002). GAMOVA did not show a significant relationship between overall genetic profile and hand-vein constriction (P=0.29), which indicates that population stratification did not contribute to this phenotype.
CONCLUSIONS:
Locally infused tyramine produced dose-dependent pressor responses, predicted by family history of hypertension, sex, and genetic variants at loci, particularly CHGB, that encode the biosynthesis, storage, and metabolism of catecholamines. Such variants may influence the complex heritability of adrenergic responses and perhaps hypertension.
AuthorsMaple M Fung, Carie Nguyen, Parag Mehtani, Rany M Salem, Brandon Perez, Brenda Thomas, Madhusudan Das, Nicholas J Schork, Sushil K Mahata, Michael G Ziegler, Daniel T O'Connor
JournalCirculation (Circulation) Vol. 117 Issue 4 Pg. 517-25 (Jan 29 2008) ISSN: 1524-4539 [Electronic] United States
PMID18180394 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • CHGB protein, human
  • Catecholamines
  • Chromogranin B
  • Tyramine
Topics
  • Adult
  • Blood Pressure
  • Catecholamines (genetics, physiology)
  • Chromogranin B (genetics, physiology)
  • Dose-Response Relationship, Drug
  • Ethnicity
  • Family Health
  • Female
  • Genetic Variation
  • Humans
  • Hypertension
  • Inheritance Patterns
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Presynaptic Terminals (drug effects)
  • Sex Factors
  • Tyramine (administration & dosage)
  • Vasoconstriction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: